| Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data F Favero, T Joshi, AM Marquard, NJ Birkbak, M Krzystanek, Q Li, ... Annals of Oncology 26 (1), 64-70, 2015 | 757 | 2015 |
| Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ... Cell 173 (3), 595-610. e11, 2018 | 622 | 2018 |
| Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma S Kelderman, B Heemskerk, H Van Tinteren, RRH Van Den Brom, ... Cancer Immunology, Immunotherapy 63, 449-458, 2014 | 379 | 2014 |
| Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs AM Marquard, AC Eklund, T Joshi, M Krzystanek, F Favero, ZC Wang, ... Biomarker research 3, 1-10, 2015 | 271 | 2015 |
| Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer Z Sztupinszki, M Diossy, M Krzystanek, L Reiniger, I Csabai, F Favero, ... NPJ breast cancer 4 (1), 16, 2018 | 229 | 2018 |
| A comprehensive survey of the mutagenic impact of common cancer cytotoxics B Szikriszt, Á Póti, O Pipek, M Krzystanek, N Kanu, J Molnár, D Ribli, ... Genome biology 17, 1-16, 2016 | 188 | 2016 |
| Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions J Zámborszky, B Szikriszt, JZ Gervai, O Pipek, Á Póti, M Krzystanek, ... Oncogene 36 (6), 746-755, 2017 | 162 | 2017 |
| A clonal expression biomarker associates with lung cancer mortality D Biswas, NJ Birkbak, R Rosenthal, CT Hiley, EL Lim, K Papp, S Boeing, ... Nature medicine 25 (10), 1540-1548, 2019 | 103 | 2019 |
| Detection of molecular signatures of homologous recombination deficiency in prostate cancer with or without BRCA1/2 mutations Z Sztupinszki, M Diossy, M Krzystanek, J Borcsok, MM Pomerantz, V Tisza, ... Clinical Cancer Research 26 (11), 2673-2680, 2020 | 90 | 2020 |
| The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer Z Baranyai, M Krzystanek, V Jósa, K Dede, E Ágoston, M Szász, D Sinkó, ... Thrombosis and haemostasis 112 (03), 483-490, 2014 | 86 | 2014 |
| Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors M Diossy, L Reiniger, Z Sztupinszki, M Krzystanek, KM Timms, C Neff, ... Annals of Oncology 29 (9), 1948-1954, 2018 | 75 | 2018 |
| Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer V Josa, M Krzystanek, AC Eklund, F Salamon, A Zarand, Z Szallasi, ... International Journal of Surgery 18, 1-6, 2015 | 75 | 2015 |
| TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen AM Marquard, NJ Birkbak, CE Thomas, F Favero, M Krzystanek, ... BMC medical genomics 8, 1-13, 2015 | 72 | 2015 |
| Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer Y Su, A Subedee, N Bloushtain-Qimron, V Savova, M Krzystanek, L Li, ... Cell reports 11 (10), 1549-1563, 2015 | 70 | 2015 |
| Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers NJ Birkbak, Y Li, S Pathania, A Greene-Colozzi, M Dreze, ... Annals of Oncology 29 (4), 903-909, 2018 | 52 | 2018 |
| Expression of apolipoprotein B in the kidney attenuates renal lipid accumulation M Krzystanek, TX Pedersen, ED Bartels, J Kjæhr, EM Straarup, ... Journal of biological chemistry 285 (14), 10583-10590, 2010 | 48 | 2010 |
| The genome of the chicken DT40 bursal lymphoma cell line J Molnár, Á Póti, O Pipek, M Krzystanek, N Kanu, C Swanton, GE Tusnády, ... G3: Genes, Genomes, Genetics 4 (11), 2231-2240, 2014 | 35 | 2014 |
| Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut O Pipek, D Ribli, J Molnar, A Poti, M Krzystanek, A Bodor, GE Tusnady, ... BMC bioinformatics 18, 1-11, 2017 | 32 | 2017 |
| A robust prognostic gene expression signature for early stage lung adenocarcinoma M Krzystanek, J Moldvay, D Szüts, Z Szallasi, AC Eklund Biomarker Research 4, 1-7, 2016 | 31 | 2016 |
| A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures M Diossy, Z Sztupinszki, J Borcsok, M Krzystanek, V Tisza, S Spisak, ... NPJ Precision Oncology 5 (1), 55, 2021 | 25 | 2021 |
James LarkinRoyal Marsden Hospital / Institute of Cancer Research, London, UKDirección de correo verificada de rmh.nhs.uk